SK

Scott D. Kuduk

Merck: 18 patents #1 of 1,208Top 1%
NT Novira Therapeutics: 1 patents #6 of 10Top 60%
Overall (2017): #1,713 of 506,227Top 1%
19
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9828368 Oxazole orexin receptor antagonists Nigel J. Liverton, Douglas C. Beshore, Yunfu Luo, Na Meng, Tingting Yu 2017-11-28
9765057 3-ester-4 substituted orexin receptor antagonists Jason W. Skudlarek 2017-09-19
9745284 2-pyridyloxy-4-ether orexin receptor antagonists Jason W. Skudlarek 2017-08-29
9732077 Diazepane orexin receptor antagonists Thomas S. Reger, Anthony J. Roecker 2017-08-15
9725434 Hydroxy-substituted orexin receptor antagonists Nigel Liverton, Jason W. Skudlarek 2017-08-08
9708273 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators Douglas C. Beshore, Christina Ng DiMarco, Thomas J. Greshock 2017-07-18
9695163 Thiazole orexin receptor antagonists Nigel Liverton, Douglas C. Beshore, Yunfu Luo, Na Meng, Tingting Yu 2017-07-04
9676751 2-amino-3-ester-pyridl orexin receptor antagonists Jason W. Skudlarek 2017-06-13
9663513 Pyrimidine PDE10 inhibitors Casey Cameron McComas, Thomas S. Reger 2017-05-30
9643955 2-pyridyloxy-3-nitrile-4-substituted orexin receptor antagonists Jason W. Skudlarek 2017-05-09
9624197 2-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonists Jason W. Skudlarek 2017-04-18
9617246 Thioether-piperidinyl orexin receptor antagonists Jason W. Skudlarek 2017-04-11
9586950 2-pyridyloxy-3-ester-4-nitrile orexin receptor antagonists Jason W. Skudlarek 2017-03-07
9586934 2-pyridyloxy-4-methyl orexin receptor antagonists Jason W. Skudlarek 2017-03-07
9556145 2-pyridyloxy-4-ester orexin receptor antagonists Jason W. Skudlarek 2017-01-31
9556190 Piperidinyloxy lactone orexin receptor antagonists Jason W. Skudlarek 2017-01-31
9550779 Derivatives and methods of treating hepatitis B infections George D. Hartman 2017-01-24
9550786 4-fluoropiperidine orexin receptor antagonists Andrew Cooke, Craig A. Stump, Peter D. Williams 2017-01-24
9546152 2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists Jason W. Skudlarek 2017-01-17